VERA THERAPEUTICS INC. - CLASS A COMMON STOCK

Vera Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

16 май 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Present at Upcoming Conferences in May 2022

05 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Two Oral Presentations at the 59th European Renal Association – European Dialysis and Transplant Association Congress Featuring New Clinical Data on Atacicept in IgA Nephropathy and in Systemic Lupus Erythematosus

03 май 2022 16:33:34 Источник Nasdaq GlobeNewswire

Vera Therapeutics Selected to Present Interim Phase 2 Data for MAU868 to Treat BK Virus in Kidney Transplant Patients as Oral Late-Breaker at the American Transplant Congress 2022

02 май 2022 19:06:09 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Appointment of Michael M. Morrissey, Ph.D., as Chairman of its Board of Directors

12 апр 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

24 мар 2022 06:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Host BK Virus Webinar Featuring Stanley C. Jordan, M.D., World-Renowned Transplant Nephrologist and Pioneering Kidney Transplant Researcher

21 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Host Business Update Call

17 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference

01 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

14 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

10 фев 2022 08:46:50 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock

07 фев 2022 17:24:50 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis

18 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 янв 2022 07:30:01 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients

17 дек 2021 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors

14 дек 2021 07:30:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021

10 ноя 2021 16:15:01 Источник Nasdaq GlobeNewswire

Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

10 ноя 2021 07:15:00 Источник Nasdaq GlobeNewswire

Vera Therapeutics Presents Phase 2a Data Showing Atacicept Reduces Serum Gd-IgA1 in Patients with IgA Nephropathy at the American Society of Nephrology Kidney Week 2021

04 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire

Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting

13 окт 2021 07:30:00 Источник Nasdaq GlobeNewswire